ANLN and pancreatic neoplasm: We explored whether the MIR600HG/hsa-miR-342-3p/ANLN network could be used as an indicator to evaluate the prognosis of patients with pancreatic cancer by investigating the association of the RNA network and OS in patients with pancreatic cancer using a multivariate Cox regression analysis.